pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,256 catalysts · 5,256 phase readout · 2,309 8k filing · 315 pdufa · 259 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 38 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: drug expiry×type: phase readout×clear all
type
  • phase readout5,256
  • 8k filing2,309
  • pdufa315
  • earnings259
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT06783621: A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica Products

Sponsor: AbbVie. Phase: PHASE4. Conditions: Facial Contouring

full page →ctgov ↗
›COMPLETEDphase readoutNCT06044714: Effects of Acupuncture on Perceived Stress and Health in Military Service Members

Sponsor: United States Naval Medical Center, San Diego. Phase: NA. Conditions: Perceived Stress

full page →ctgov ↗
›RECRUITINGphase readoutNCT07505004: Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures

Sponsor: Praxis Precision Medicines. Phase: PHASE3. Conditions: Focal Epilepsy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT02636504: Evaluation of Three Pulp Vitality Tests

Sponsor: Columbia University. Phase: . Conditions: Dental Pulp Diseases, Dental Pulp Vitality Testing

full page →ctgov ↗
›RECRUITINGphase readoutNCT07459504: SMART Diets for MASLD

Sponsor: Michigan State University. Phase: PHASE2. Conditions: Metabolic-dysfunction Associated Steatotic Liver Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT01050504: Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

Sponsor: University of Washington. Phase: . Conditions: Localized Renal Pelvis and Ureter Urothelial Carcinoma, Malignant Solid Neoplasm, Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Neoplasm in the Soft Tissues, Metastatic Renal Pelvis and Ureter Urothelial Carcinoma, Recurrent Bladder Carcinoma, Recurrent Prostate Carcinoma, Recurrent Renal Pelvis and Ureter Urothelial Carcinoma, Stage IV Bladder Cancer AJCC v7, Stage IV Bladder Urothelial Carcinoma AJCC v7, Stage IV Prostate Cancer AJCC v7

full page →ctgov ↗
›COMPLETEDphase readoutNCT04577404: Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Sponsor: Tanabe Pharma America, Inc.. Phase: PHASE3. Conditions: Amyotrophic Lateral Sclerosis (ALS)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07336147: Dostarlimab, Cisplatin and Etoposide in Combination With Radiotherapy in Sandwich Sequence for Small Cell Neuroendocrine Cervical Carcinoma

Sponsor: Chang Gung Memorial Hospital. Phase: PHASE2. Conditions: Female

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07397247: Tonic Motor Activation (TOMAC) Therapy in Patients With Restless Legs Syndrome and Dopaminergic Augmentation

Sponsor: Noctrix Health, Inc.. Phase: NA. Conditions: Restless Legs Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT05030038: Oral Aromatase Inhibitors Modify the Gut Microbiome

Sponsor: Wake Forest University Health Sciences. Phase: . Conditions: Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07357558: A Qualitative Study Investigating the Lived Experiences and Impact of Reproductive Issues in Adults With Primary Ciliary Dyskinesia

Sponsor: University Hospital Southampton NHS Foundation Trust. Phase: . Conditions: Primary Ciliary Dyskinesia (PCD)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05070858: A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis

Sponsor: Regeneron Pharmaceuticals. Phase: PHASE3. Conditions: Generalized Myasthenia Gravis

full page →ctgov ↗
›COMPLETEDphase readoutNCT07145658: Multivitamin for Health and Cognition

Sponsor: Dr Anthony Hobson. Phase: NA. Conditions: Healthy, Cognition, Health

full page →ctgov ↗
›RECRUITINGphase readoutNCT06666348: Phase 1/2 Study of Mirdametinib + Vinblastine for Newly Diagnosed/Previously Untreated PLGG + Activation of MAPK

Sponsor: St. Justine's Hospital. Phase: PHASE1. Conditions: Pediatric Low-grade Glioma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06471426: The Effect of Osteopathic Treatment on Craniocervico-Mandibular Dysfunction

Sponsor: Edward Via Virginia College of Osteopathic Medicine. Phase: NA. Conditions: Headache, Neck Pain

full page →ctgov ↗
›COMPLETEDphase readoutNCT03328026: Combination Study of SV-BR-1-GM With Retifanlimab

Sponsor: BriaCell Therapeutics Corporation. Phase: PHASE1. Conditions: Breast Cancer, Breast Neoplasm, Metastatic Breast Cancer, Breast Cancer Metastatic

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07593326: Midwife-Led Antenatal Perineal Massage Education in Primiparous Pregnant Women

Sponsor: Atlas University. Phase: NA. Conditions: Pregnancy, Fear of Childbirth, Antenatal Education

full page →ctgov ↗
›COMPLETEDphase readoutNCT03555578: Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)"

Sponsor: Takeda. Phase: . Conditions: Spinal and Bulbar Muscular Atrophy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05288985: Impact of Loco-regional Analgesia Following Placement of Erector Spinae Plane Catheter in Addition to Systemic Analgesia in Patients With Thoracic Trauma

Sponsor: Centre Hospitalier Departemental Vendee. Phase: NA. Conditions: Trauma Abdomen

full page →ctgov ↗
›COMPLETEDphase readoutNCT04250077: We The Village Family Support Study

Sponsor: We The Village, Inc.. Phase: NA. Conditions: Community Reinforcement And Family Training, Family Health, Substance-Related Disorders

full page →ctgov ↗
›RECRUITINGphase readoutNCT07444957: Safety and Effectiveness of the Crystalline Sirolimus-Eluting Device in Patients With Coronary Artery Disease

Sponsor: Fundación Interhospitalaria para la Investigación Cardiovascular FIC. Phase: . Conditions: Coronary Arterial Disease (CAD), NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI), Stable Angina, Unstable Angina, NSTEMI, Drug Coated Balloon, ST-Elevation Myocardial Infarction, Silent Ischemia

full page →ctgov ↗
›RECRUITINGphase readoutNCT06605001: Development, Attention, and Inhibition Study

Sponsor: University of California, Davis. Phase: NA. Conditions: The Ability to Delay Gratification

full page →ctgov ↗
›RECRUITINGphase readoutNCT07278375: Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome

Sponsor: HELP for NOWS Consortium. Phase: . Conditions: Neonatal Opioid Withdrawal Syndrome

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07412275: Microwave Intervention Under Local Anesthesia

Sponsor: Koelis. Phase: NA. Conditions: Localised Prostate Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07369895: Clinical Study of O&D-001 Injection in the Treatment of Relapsed or Refractory Multiple Myeloma

Sponsor: O&D BioTech Group CO., Limited. Phase: PHASE1. Conditions: Relapsed or Refractory Multiple Myeloma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04773457: Neutrophil Phenotypic Profiling and Surgical Site Infections in Surgical Patients

Sponsor: Boston Children's Hospital. Phase: . Conditions: Surgical Site Infection

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06463457: Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED)

Sponsor: Atish Choudhury, MD. Phase: PHASE2. Conditions: Prostate Cancer, Advanced Prostate Cancer, Hormone Sensitive Prostate Cancer

full page →ctgov ↗
›TERMINATEDphase readoutNCT06535477: Fall Risk Assessment With an Innovative Device for Quantifying Gait and Static Balance in Geriatric Consultation

Sponsor: Gérond'if. Phase: NA. Conditions: Risk of Falling in the Elderly

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07347457: Functional Rehabilitation Effects on Exercise-induced Hypoalgesia in Chronic Low Back Pain

Sponsor: Clinique de la Mitterie. Phase: NA. Conditions: Low Back Pain

full page →ctgov ↗
›COMPLETEDphase readoutNCT07495553: Web-Based Filial Therapy In Pediatric Cancer

Sponsor: serap güleç keskin. Phase: NA. Conditions: Pediatric Cancer, Parental Stress, Parenting Anxiety

full page →ctgov ↗
›RECRUITINGphase readoutNCT06075745: Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: PHASE2. Conditions: Liver Transplant

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07471672: Spot Compression Ultrasound Compared to Traditional Breast Ultrasound

Sponsor: Duke University. Phase: NA. Conditions: Breast Mass

full page →ctgov ↗
›RECRUITINGphase readoutNCT06283472: Enhancing Prospective Thinking in Early Recovery (BEAM)

Sponsor: Indiana University. Phase: NA. Conditions: Alcohol Use Disorder

full page →ctgov ↗
›TERMINATEDphase readoutNCT05899595: Effects of a Personalized Physical Training to Reduce Fatigue

Sponsor: Centre Hospitalier Universitaire de Saint Etienne. Phase: NA. Conditions: Fatigue Syndrome, Chronic

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03513939: A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch™ for Clinical Islet Transplantation

Sponsor: Sernova Biotherapeutics Inc.. Phase: PHASE1. Conditions: Type 1 Diabetes Mellitus

full page →ctgov ↗
›COMPLETEDphase readoutNCT05289739: Exercise Training in Childhood Cancer

Sponsor: Johannes Gutenberg University Mainz. Phase: NA. Conditions: Pediatric Oncology

full page →ctgov ↗
›RECRUITINGphase readoutNCT06339177: Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: Lymphohistiocytosis, Hemophagocytic, Secondary Hemophagocytic Lymphohistiocytosis, Macrophage Activation Syndrome, Hyperinflammatory Syndromes

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07336277: Sleep Quality and the Efficacy of a Multimodal Sleep Pathway in Hospitalized Orthopedic Trauma Patients

Sponsor: Emory University. Phase: PHASE3. Conditions: Orthopedic Trauma, Sleep Quality

full page →ctgov ↗
›RECRUITINGphase readoutNCT07238075: ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers

Sponsor: Adcytherix SAS. Phase: PHASE1. Conditions: Advanced Malignancy, Advanced Solid Cancers, Metastatic Solid Tumors

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06746675: Evaluating the Healthy Families PrEP Program for Women at Risk for HIV

Sponsor: Yale University. Phase: NA. Conditions: HIV, Pregnancy, Pre-Exposure Prophylaxis of HIV Infection

full page →ctgov ↗
›RECRUITINGphase readoutNCT06807957: Inspiratory Muscle Training in Amateur CrossFit® Athletes

Sponsor: Federal University of the Valleys of Jequitinhonha and Mucuri. Phase: NA. Conditions: Healthy

full page →ctgov ↗
›RECRUITINGphase readoutNCT06975657: Well-being Skills for Reentry

Sponsor: University of Wisconsin, Madison. Phase: NA. Conditions: Formerly Incarcerated Adults

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06050577: The Effect of Oral Semaglutide on Bone Turnover in Patients With T2D: a Randomized Placebo-controlled Clinical Trial

Sponsor: Odense University Hospital. Phase: PHASE2. Conditions: Type 2 Diabetes, Osteopenia

full page →ctgov ↗
›TERMINATEDphase readoutNCT01980277: Phase Ib/II Study of LY2780301 in Combination With Weekly PACLITAXEL in HER2-metastatic Breast Cancer

Sponsor: Institut Paoli-Calmettes. Phase: PHASE1. Conditions: Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07028372: Long Term Follow-up of Cardiac Arrest Survivors Exposed to Ultra-rapid Cooling

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Cardiac Arrest (CA), Resuscitated Sudden Cardiac Death, Post Cardiac Arrest Patient Who Was Treated by Hypothermia Protocol

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05359445: IMA401 TCER® in Recurrent and/or Refractory Solid Tumors, Alone or in Combination With a Checkpoint Inhibitor

Sponsor: Immatics Biotechnologies GmbH. Phase: PHASE1. Conditions: Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult, Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07585695: Coronary Artery Disease Screening in Patients With Chronic Kidney Disease

Sponsor: University Hospital, Grenoble. Phase: . Conditions: Chronic Kidney Disease (CKD), Coronary Artery Disease (CAD)

full page →ctgov ↗
›RECRUITINGphase readoutNCT05408845: Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

Sponsor: NRG Oncology. Phase: PHASE2. Conditions: Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage III Major Salivary Gland Cancer AJCC v8, Stage IV Major Salivary Gland Cancer AJCC v8, Unresectable Salivary Gland Carcinoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT00515372: Depression Treatment and Screening in Ovarian Cancer Patients

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06814795: Medically Tailored Meals for Kids

Sponsor: UNC Lineberger Comprehensive Cancer Center. Phase: NA. Conditions: Pediatric Cancer

full page →ctgov ↗
← prev
page 39 of 106
next →